NCT05917106Recruiting
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Source: ClinicalTrials.gov · Last updated 11 Dec 2025
Brief summary (registry, in English)
To conduct prospective studies to confirm the value of circulating tumor DNA and its abnormal methylation in longitudinal monitoring of patients undergoing kidney cancer surgery.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 450 (estimated)
- First submitted
- 9 Jun 2023
- Start date
- 26 Dec 2022
- Primary completion date
- Jun 2028
- Lead sponsor
- Jinling Hospital, China
- Diseases
- Kidney cancer, Childhood cancers
- NCT number
- NCT05917106
What you commit to
- Study type: Observational
- Planned participants: 450
- From 26 Dec 2022 to the primary completion date, Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Had received any antitumor therapy before
Other illness
- Had other cancers
- Known or suspected active autoimmune disease
- Informed consent is not possible due to medical or psychiatric problems
- Have clinical symptoms or diseases of the heart that are not well controlled
Other
- Patients judged by the investigators to be unsuitable for inclusion in this study
Who the study is looking for
- Newly diagnosed renal cell carcinoma
- Without any treatment
- Agree and accept radical surgical treatment
- Signed written informed consent
- ECOG(Eastern Cooperative Oncology Group) performance is 0 or 1
- Follow up protocol and related procedures
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China Coordinator of this site? Confirm its status | Nanjing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.